<DOC>
	<DOCNO>NCT02870400</DOCNO>
	<brief_summary>The primary objective study assess safety tolerability single ascending dos REGN2477 healthy woman childbearing potential .</brief_summary>
	<brief_title>A Study Examine Safety Tolerability Single Ascending Doses REGN2477</brief_title>
	<detailed_description />
	<criteria>1 . Healthy woman childbearing potential 18 65 year age , significant health issue clinically significant abnormal laboratory finding 2 . A body mass index ( BMI ) 18 30 kg/m2 , inclusive 3 . Provide sign informed consent 1 . Significant illness history significant illness 2 . Clinically significant abnormal CBC , clinical chemistry , urine analysis screen 3 . Current smoker former smoker stop smoke within 3 month prior screen 4 . Positive urine drug test result screen , history drug alcohol abuse 5 . Donation loss , blood within 8 week prior screen , plasma 14 day prior screen 6 . History diabetes 7 . Abnormal blood pressure ( BP ) 8 . History gynecological disorder malignancy ; history breast malignancy ; history benign gynecological breast lesion require medical treatment follow 9 . Reduced renal function 10 . Known history chronic hepatitis HIV 11 . Clinically significant ECG abnormalities 12 . Participation clinical research study within 30 day , 5 halflives , study drug , whichever great , long period per regional requirement , prior screen visit 13 . Exposure biological drug within 3 month screen visit ( name drug duration previous exposure record ) . Vaccination within 4 week screen visit . 14 . History hypersensitivity reaction vaccines biologics 15 . History hypersensitivity doxycycline tetracycline antibiotic 16 . History osteoporosis require osteoporosis treatment PTH , bisphosphonates , denosumab 17 . Subject use hormone replacement therapy thyroid replacement therapy exclude , unless stable dos therapy least 6 month remain stable dose duration trial 18 . Use systemic glucocorticoid , include oral glucocorticoid , 10 day , within 3 month prior screen .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>